Skip to content
Super promo!Reishi−50%59.50 zł119 zł (regular price)
Only 28 left at 59.50 zł, then 71.40 złSee Reishi →
Free delivery in Poland from 299 PLN

Reishi capsules, powder, or drops? Which form fits which ritual

Reishi capsules, reishi powder, or drops. Same raw material, three formats: we compare convenience, taste and dosing so you can pick the right fit for your day.

Mateusz Rosa

TCM therapist · Doctor of Acupuncture (WFAS) · author of a book on functional mushrooms

5 min read

Reishi capsules, powder, or drops? Which form fits which ritual
Contents

You're choosing between reishi capsules, reishi powder, and drops, and you're not sure how these forms actually differ, since it's the same mushroom underneath. The answer is simpler than it looks: it's the same raw material, just different convenience. This post shows when each format of reishi fits best into your day.

How do the three reishi forms differ?

Reishi capsules and powder contain the same standardized fruiting-body extract; the difference is the delivery method. Drops are a separate product: a liquid, triple-extracted extract (DER 10:1, water and food-grade alcohol), available only in the PRIME line. A capsule seals a serving inside a swallowable shell, powder needs mixing with a liquid, and drops go straight into a drink or are taken directly.

That choice doesn't change what's inside, it changes how easily you can fit the supplement into your own day. A capsule has no taste and needs no prep, powder gives you control over what you add it to, and drops are the fastest to dose because there's no scoop to measure. In our LONGEVITY line, capsules and powder come from a 10:1 extract blended in equal parts with powdered fruiting body; in our PRIME line, the ratio is 80% extract to 20% fruiting body, and PRIME drops are a pure liquid extract with no 80/20 blend.

When do capsules make sense?

Reishi capsules work best when precise serving size and zero taste matter most, for example while traveling, at work, or when the bitter taste of the fruiting body simply isn't for you.

You don't have to measure or mix anything, just swallow it with water, which makes this form convenient when you want the ritual to be as simple as possible. In our PRIME line, a serving is 3 capsules of 450 mg each (1.35 g total), and in our LONGEVITY line it's also 3 capsules a day. Capsules are a good choice if you travel often or want a supply that won't spill in a bag.

When does powder make sense?

Reishi powder makes sense when you want to fold the mushroom into a specific drink or meal, such as morning coffee, a smoothie, or oatmeal, and the slightly bitter, earthy taste of the fruiting body doesn't bother you.

One practical rule: don't pour boiling water over the powder, since high heat can affect the structure of some compounds in the extract. It's better to add it to a cooler liquid or mix it into food. In our LONGEVITY line, a serving is 2-3 scoops in the evening; in our PRIME line, it's 2 scoops a day (1.5 g), of which 1200 mg is extract, including a minimum of 360 mg beta-glucans. Powder also gives you flexibility, since you can adjust the amount day to day within the recommended serving.

When do drops make sense?

Reishi drops are the fastest way to fold the mushroom into a ritual, since you just count out a serving and add it to a drink or take it directly under the tongue, without measuring or drinking water alongside it.

This form suits people who value simplicity and speed, especially when the ritual is meant to take literally a few seconds. The exact serving volume and drop concentration vary between products, so always check the dosage on the label of the specific package, not on general advice online. A typical serving is 20 drops (333 mg of extract) in a drink or directly, in the evening.

Comparison table of the three forms

FormConvenienceTasteDose controlBest timing
CapsulesHighest, just waterNoneFixed, 1 capsule = same servingTravel, work, evening
PowderNeeds mixingBitter, earthyFlexible, scoop by scoopAdded to a drink or food
DropsVery high, no water neededMild in a drinkYou count the dropsA quick evening ritual

How to choose in 3 questions

Instead of reading other people's opinions, answer three questions about your own day, since that's what determines which form actually sticks long-term.

  • Do you want zero taste and zero prep? Choose capsules.
  • Do you already have a morning or evening drink habit that's easy to add something to? Choose powder or drops.
  • Do you want the fastest possible ritual, with nothing to measure? Choose drops.

Frequently asked questions about reishi forms

Does powder work differently from capsules made from the same extract? No, it's the same standardized reishi extract in a different physical form. The difference is in the delivery method, not the extract's composition.

Can you combine forms, for example capsules in the morning and powder in the evening? Yes, as long as you stick to the total recommended daily serving on the label and don't double the dose by counting both forms separately.

Why shouldn't you pour boiling water over reishi powder? High water temperature can affect the structure of some compounds in the extract, so it's safer to add the powder to a cooler liquid or to food, not directly into boiling water.

Which form is best to start with if you've never used reishi before? Capsules are usually the simplest entry point, since they remove questions about taste, mixing, and measuring, giving you just a serving to swallow.

For exactly how much reishi to take daily and at what time, see our detailed post on reishi dosage. If you're curious what the numbers on an extract label actually mean, check out reishi extract 10:1, and for the evening ritual itself, read reishi's evening ritual.


This content is for educational purposes only and does not constitute medical advice. A food supplement does not replace a varied diet or a healthy lifestyle. If in doubt, consult your doctor or pharmacist.

Reishi in scientific research

What was studied, on how many people and with what level of evidence. This overview describes studies, not the effects of a product.

8

human studies

3

placebo-controlled RCTs

2005–2025

years of publication

  • Jin X. et al., 2016

    A

    Cochrane systematic review with meta-analysis

    5 RCTs, total number of people not reported

    The review collected randomised studies on the use of Ganoderma lucidum in the context of oncological treatment. The authors noted unsatisfactory methodological quality of the primary studies, incomplete outcome reporting, no long-term survival data, and adverse events reported in only one study.

    PMID 27045603
  • Klupp N.L. et al., 2015

    A

    Cochrane systematic review with meta-analysis

    5 studies, 398 people

    The review collected randomised studies on the effect of Ganoderma lucidum on cardiovascular risk factors in people with type 2 diabetes. The authors noted that only 3 of 5 studies provided data suitable for statistical analysis.

    PMID 25686270
  • Jafari A. et al., 2025

    B

    systematic review with meta-analysis, GRADE assessment

    17 RCTs, 971 people

    The review collected clinical trials on Ganoderma lucidum supplementation regarding anthropometric, metabolic, inflammatory and liver markers. GRADE-assessed evidence quality was very low for all analysed outcomes.

    PMID 40510787
  • Zhong L. et al., 2019

    B

    systematic review with meta-analysis of RCTs

    23 studies, 4246 people

    The review collected randomised studies on Coriolus versicolor and Ganoderma lucidum preparations used as adjunct therapy in oncology patients. Studies were conducted almost exclusively in Asia, with heterogeneous preparations and doses.

    PMID 31333449
  • Klupp N.L. et al., 2016

    C

    RCT, double-blind, placebo-controlled

    84 people

    The study examined the effect of Ganoderma lucidum, alone and combined with Cordyceps sinensis, on glycaemic parameters and other cardiovascular risk factors in 84 people with type 2 diabetes and metabolic syndrome. Observation period limited to 16 weeks.

    PMID 27511742
  • Noguchi M. et al., 2008

    C

    RCT

    88 men over 49 years old

    The study examined the effect of an ethanol extract of Ganoderma lucidum on lower urinary tract symptoms in 88 men over 49 years old. The authors recommended further evaluation on a larger sample and over a longer period.

    PMID 18097505
  • Aref M. et al., 2023

    E

    meta-analysis of animal studies · preclinical studies (in vitro and rodent)

    not applicable, 49 papers

    The review collected animal studies on the effect of Ganoderma lucidum on serum lipid profile. Dose variation between studies, scope limited to animal models.

    PMID 38116485
  • Tang W. et al., 2005

    C

    RCT, double-blind, placebo-controlled

    132 people (China)

    The study examined the effect of 8 weeks of taking a Ganoderma lucidum polysaccharide extract on a neurasthenia symptom severity scale score in 132 Chinese patients. Limitations were not stated explicitly in the abstract.

    PMID 15857210
  • Cui X.Y. et al., 2012

    E

    animal study (rats) · preclinical studies (in vitro and rodent)

    not applicable

    The rat study examined the effect of a 3-day Ganoderma lucidum extract administration (80 mg/kg) on total sleep time and NREM sleep, and on TNF-α levels in blood and brain, using TNF-α blocking antibodies to test the mechanism.

    PMID 22207209
  • Chu Q.P. et al., 2007

    E

    animal study (rats) · preclinical studies (in vitro and rodent)

    not applicable

    The rat study examined the effect of an aqueous extract (80 and 120 mg/kg) on sleep architecture in healthy animals and on pentobarbital-induced sleep, using flumazenil to test the GABAergic mechanism.

    PMID 17383716
  • Wang X. et al., 2025

    C

    RCT, double-blind, placebo-controlled

    110 randomised (55/group in final analysis), 12 weeks

    The study examined the effect of 12 weeks of Ganoderma lucidum spore oil supplementation (3 g daily, approx. 1 g triterpenes) on lipid profile and kidney/liver safety in people with borderline elevated triglycerides. Limited to a population with borderline hypertriglyceridemia and a short 12-week observation period.

    PMID 40077714

Evidence levels: A · Cochrane review · B · systematic review · C · placebo RCT · D · pilot RCT · E · preclinical studies

What these studies don't say

  • Samples are usually small, most from a single population.
  • Results describe research interventions, not a dietary supplement.
  • The presence of a study is not a health claim.

Source: Aloha Fungi literature review, 1 September 2026; entries verified via PubMed or by DOI (Crossref). See the research

Discover functional mushrooms

© 2026 Aloha Fungi™